Search results
Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports
AOL· 6 days agoThe drugmaker was set to pay between $200 million and $250 million in the settlement, the newspaper reported, citing two people briefed on the deal. The settlement was disclosed in a court filing ...
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With Less Than $100 Right Now | The...
The Motley Fool· 2 days agoIf you have an extra $100 to invest, you could set yourself up with dividends from Realty Income (O...
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot
KFGO· 5 days ago(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and...
Vepdegestrant shows promise in breast cancer trial By Investing.com
Investing.com· 6 days agoArvinas, Inc. (NASDAQ: ARVN) and Pfizer Inc. (NYSE: NYSE:PFE) today announced continued positive...
Pfizer offers up to $250 mln to settle thousands of Zantac cancer lawsuits, FT reports
Reuters· 6 days agoPfizer has agreed offer payment of up to $250 million to settle more than 10,000 lawsuits in the...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots
Barrons.com· 2 days agoAfter disappointing sales for their Covid vaccines last year, Moderna, Novavax, and Pfizer are...
3 High-Yield Dividend Stocks I'm Buying Hand Over Fist
Motley Fool via Yahoo Finance· 2 days agoHowever, the advantages this stock offers make the extra tax filing requirements worth the effort to...
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks via Yahoo Finance· 2 days agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody...
Woburn startup Gradiant has new tech to zap ‘forever chemicals’ - The Boston Globe
The Boston Globe· 16 hours agoAmid a growing awareness that drinking water is contaminated with harmful “forever chemicals,” one...
How GSK CEO Emma Walmsley kept her job and turned a belligerent activist investor into an ally
Fortune· 22 hours agoA vaccine breakthrough helped Walmsley keep her job after the hedge fund known for taking stakes in underperforming companies argued in 2021 that Britain’s oldest drugmaker had “lost its way ...